New multicenter study data reveals that targeted sepsis testing at triage in the ED may be key to preserving inpatient bed capacity for the most severe patients.
Cytovale’s rapid sepsis diagnostic IntelliSep drove a 56% relative increase in ED discharges among low risk patients and lowered inpatient bed utilization, without increasing the rate of return visits. Study results underscore that smarter sepsis decision making at triage can directly impact hospital capacity by increasing safe discharge decisions.
The study evaluated 4,650 patients with signs and symptoms of infection tested with IntelliSep over the course of four months at four hospitals in the Franciscan Missionaries of Our Lady Health System in Louisiana and Mississippi. When used early in triage, IntelliSep’s risk stratification and decision-making insights helped clinicians reduce unnecessary admissions and discharge patients with greater confidence.
Key study findings:
56% relative increase in ED discharge rate for patients classified as low sepsis risk (IntelliSep Band 1)
No significant change in ED 30-day return rates, underscoring patient safety was uncompromised
IntelliSep takes approximately eight minutes from blood to result, and can be used in ED triage with a standard blood draw to risk stratify patients.
